Septerna

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

AC Immune CEO bids adieu—Chutes & Ladders

AC Immune CEO bids adieu. Bicara picks up commercial head from Replimune. Infinimmune names CMO to lead clinical push.
finance numbers tape money

Novo inks $2.2B deal for Septerna's preclinical obesity programs

May 14, 2025 7:00am
A young researcher with wavy black hair and wearing a white coat looks into a microscope

Septerna drops lead asset over side effects 4 months after IPO

Feb 18, 2025 9:43am
bullish sentiment

Why biotechs can benefit from the 'rational' IPO environment

Jan 24, 2025 10:30am
The Top Line

What can we learn from 2024’s biotech IPOs?

Dec 6, 2024 8:44am
IPO initial public offering

Septerna goes public with upsized offering of $288M

Oct 25, 2024 10:29am